Skip to content

The value of contrast-enhanced ultrasound microscopy in the diagnosis of follicular neoplasm

The value of contrast-enhanced ultrasound microscopy in the diagnosis of follicular neoplasm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122946
Enrollment
Unknown
Registered
2026-04-20
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

follicular neoplasm

Interventions

Gold Standard:pathologic diagnosis
Index test:Diagnostic Prediction Model for Thyroid Follicular Tumors Based on Ultrasound Micro-Imaging

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.=18 years old; 2.Patients who were diagnosed and underwent surgery at the Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine and whose preoperative ultrasound showed suspicious thyroid follicular tumors; 3.Voluntarily participate in this study and sign the informed consent form. If the subject is unable to read and sign the informed consent form due to disability or other reasons, or if the subject is a minor, their guardian must act on their behalf to conduct the informed consent process and sign the informed consent form. If the subject is unable to read the informed consent form (e.g., illiterate subjects), a witness must witness the informed consent process and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with other types of thyroid cancer. 2. Individuals allergic to ultrasound contrast agents. 3. Vulnerable groups other than the elderly/illiterate, including those with mental illnesses, cognitive impairments, critically ill patients, pregnant women, etc. 4. Other reasons the researcher believes the subject is unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Accuracy of benign and malignant diagnosis;

Countries

China

Contacts

Public ContactLi Qiang

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

liqiangsd@sina.cn+86 571 8600 6331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026